Works matching IS 15330028 AND DT 2015 AND VI 14 AND IP 3


Results: 10
    1

    FOLFIRI and Cetuximab Every Second Week for First-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer According to Phosphatase and Tensin Homolog Expression: A Phase II Study.

    Published in:
    Clinical Colorectal Cancer, 2015, v. 14, n. 3, p. 162, doi. 10.1016/j.clcc.2015.02.006
    By:
    • Personeni, Nicola;
    • Rimassa, Lorenza;
    • Verusio, Claudio;
    • Barni, Sandro;
    • Rubino, Luca;
    • Bozzarelli, Silvia;
    • Villa, Eugenio;
    • Carnaghi, Carlo;
    • Tronconi, Maria Chiara;
    • Gerardi, Chiara;
    • Galli, Francesca;
    • Floriani, Irene;
    • Destro, Annarita;
    • Raschioni, Carlotta;
    • Labianca, Roberto;
    • Santoro, Armando
    Publication type:
    Article
    2
    3

    Outcomes of Therasphere Radioembolization for Colorectal Metastases.

    Published in:
    Clinical Colorectal Cancer, 2015, v. 14, n. 3, p. 146, doi. 10.1016/j.clcc.2015.02.002
    By:
    • Abbott, Andrea M.;
    • Kim, Richard;
    • Hoffe, Sarah E.;
    • Arslan, Bulent;
    • Biebel, Ben;
    • Choi, Junsung;
    • El-Haddad, Ghassan;
    • Kis, Bela;
    • Sweeney, Jennifer;
    • Meredith, Kenneth L.;
    • Almhanna, Khaldoun;
    • Strosberg, Jonathan;
    • Shibata, David;
    • Fulp, William J.;
    • Shridhar, Ravi
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10